Literature DB >> 6217831

Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage.

K H Mills, J C Cawley.   

Abstract

Among peripheral blood T cells from 25 patients with myeloma, % OKT8+ suppressor cells were increased in all but two patients (mean 63 +/- 12%; normal 34 +/- 8%), but were present in normal absolute numbers (mean 0.5 +/- 0.3 x 10(9)/l; normal range 0.2-0.6 x 10(9)/l). OKT4+ helper cells were reduced in relative and absolute numbers (mean 40 +/- 12%, 0.3 +/- 0.2 x 10(9)/l; normal 64 +/- 8%, 0.6-1.4 x 10(9)/l). Similar results were obtained in treated and untreated cases, and in patients of different clinical stage. In the 12 patients tested, gamma Fc-rosetting T cells were present in normal numbers (mean 28 +/- 10%; normal 34 +/- 10%). In four patients with IgM disease, similar, but less marked, changes in monoclonal antibody-defined T-cell subsets were observed. The findings are discussed in relation to those in other B-cell malignancies, and it is suggested that imbalances of OKT4+ helper/OKT8+ suppressor cells may be important in the immune suppression of many of these disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6217831     DOI: 10.1111/j.1365-2141.1983.tb02021.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  27 in total

1.  Multiple myeloma: ecto-5' nucleotidase deficiency of suppressor/cytotoxic (CD8) lymphocytes is a marker for the expansion of suppressor T cells.

Authors:  M Massaia; U Dianzani; P Pioppo; E Sibilla; M Boccadoro; A Pileri
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

2.  Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial.

Authors:  Andrew R Branagan; Eamon Duffy; Randy A Albrecht; Dennis L Cooper; Stuart Seropian; Terri L Parker; Geliang Gan; Fangyong Li; Daniel Zelterman; Chandra Sekhar Boddupalli; Lin Zhang; Rakesh Verma; Thomas M Ferencz; Madhav V Dhodapkar
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-03-07

Review 3.  Clinical Development of PD-1 Blockade in Hematologic Malignancies.

Authors:  Matthew J Pianko; Aaron D Goldberg; Alexander M Lesokhin
Journal:  Cancer J       Date:  2018 Jan/Feb       Impact factor: 3.360

Review 4.  Immune checkpoint blockade for hematologic malignancies: a review.

Authors:  Matthew J Pianko; Yuzhou Liu; Srishti Bagchi; Alexander M Lesokhin
Journal:  Stem Cell Investig       Date:  2017-04-19

5.  Clinical significance of cancer-related fatigue in multiple myeloma patients.

Authors:  Kazuhito Suzuki; Nobuyuki Kobayashi; Yoji Ogasawara; Takaki Shimada; Yuichi Yahagi; Katsuki Sugiyama; Shinobu Takahara; Takeshi Saito; Jiro Minami; Hiroki Yokoyama; Yutaro Kamiyama; Atsushi Katsube; Kazuhiro Kondo; Hiroyuki Yanagisawa; Keisuke Aiba; Shingo Yano
Journal:  Int J Hematol       Date:  2018-08-28       Impact factor: 2.490

6.  Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.

Authors:  Güllü Görgün; Elisabetta Calabrese; Ender Soydan; Teru Hideshima; Giulia Perrone; Madhavi Bandi; Diana Cirstea; Loredana Santo; Yiguo Hu; Yu-Tzu Tai; Sabikun Nahar; Naoya Mimura; Claire Fabre; Noopur Raje; Nikhil Munshi; Paul Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2010-07-22       Impact factor: 22.113

7.  Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies.

Authors:  M Massaia; U Dianzani; A Bianchi; A Camponi; M Boccadoro; A Pileri
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

8.  Regulation of immunoglobulin synthesis by monocytes in multiple myeloma and benign monoclonal gammopathy.

Authors:  A Takeshita
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

9.  T-cell subsets in multiple myeloma. Impact of cytostatic treatment.

Authors:  A Wahlin; G Roos; J Holm
Journal:  Blut       Date:  1985-10

10.  Effect of chemotherapy on T-lymphocyte subsets in B-cell proliferative disorders.

Authors:  C A Emmendörffer; W J Pichler
Journal:  Blut       Date:  1985-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.